Literature DB >> 6635894

Antifungal activity in vitro of Ro 14-4767/002, a phenylpropyl-morpholine.

A Polak.   

Abstract

Minimal inhibitory concentrations (MICs) of Ro 14-4767/002 for pathogenic yeasts, Aspergillus spp., dermatophytes and other filamentous fungi were determined in dilution tests under a variety of experimental conditions and, for the most of the species and a number of different isolates. Ro 14-4767/002 showed the highest effect against dermatophytes and Cryptococcus neoformans, followed by Candida spp., whereas its activity against Aspergillus spp. was weak. Its activity against most pathogens compared favourably with antifungals of the imidazole class. The activity of Ro 14-4767/002 not only differed between the species but there was also a significant intra-species variation. The MICs were influenced by the inoculum size, the incubation time, and by the composition of the medium. The activity of the compound was significantly higher on Casitone agar than on a chemically defined medium (Yeast Nitrogen Base + glucose). Ro 14-4767/002 was also found to exert fungicidal activity which was time- and concentration-dependent.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6635894

Source DB:  PubMed          Journal:  Sabouraudia        ISSN: 0036-2174


  10 in total

1.  Fluorometric assessment of In vitro antidermatophytic activities of antimycotics based on their keratin-penetrating power.

Authors:  C N Okeke; R Tsuboi; M Kawai; H Ogawa
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Pathogenicity of Sporotrichum pruninosum and Cladosporium oxysporum, isolated from the bronchial secretions of a patient, for laboratory mice.

Authors:  S M Singh; M Singh; S Mukherjee
Journal:  Mycopathologia       Date:  1992-03       Impact factor: 2.574

3.  In vitro studies with R 51,211 (itraconazole).

Authors:  A Espinel-Ingroff; S Shadomy; R J Gebhart
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

4.  Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model.

Authors:  S M Singh; S Sharma; P K Chatterjee
Journal:  Mycopathologia       Date:  1990-12       Impact factor: 2.574

5.  In vitro activity of seven azole compounds against some clinical isolates of non-dermatophytic filamentous fungi and some dermatophytes.

Authors:  C A Oyeka; H C Gugnani
Journal:  Mycopathologia       Date:  1990-06       Impact factor: 2.574

Review 6.  Amorolfine. A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections.

Authors:  M Haria; H M Bryson
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

7.  In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.

Authors:  C N Okeke; H C Gugnani
Journal:  Mycopathologia       Date:  1987-09       Impact factor: 2.574

Review 8.  A case of cutaneous phaeohyphomycosis caused by Exserohilum rostratum, its in vitro sensitivity and review of literature.

Authors:  A Agarwal; S M Singh
Journal:  Mycopathologia       Date:  1995-07       Impact factor: 2.574

9.  Onychomycosis caused by Chaetomium globosum Kunze.

Authors:  J Naidu; S M Singh; M Pouranik
Journal:  Mycopathologia       Date:  1991-01       Impact factor: 2.574

10.  Onychomycosis caused by Scopulariopsis brumptii. A case report and sensitivity studies.

Authors:  J Naidu; S M Singh; M Pouranik
Journal:  Mycopathologia       Date:  1991-03       Impact factor: 2.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.